So sorry for my delayed response. It's been a busy week so far!
In regards to the pill, our licensing partner, Oblato, Inc., is in charge of where we seek clinical approval for NHPN-1010 and currently their focus is the FDA. Unfortunately, we're just the inventors of the pill, they're the ones responsible for getting it to the market. As such, we have no control over that part of the process so I can't tell you whether or not they will seek clinical approval in Europe, too.
And yes, our formulation is designed to treat tinnitus of all kinds. It's also worthy to mention that tinnitus is actually a type of nerve-deafness which has nothing to do with the ear drum. That means no worries for you there!
I hope that answers your questions! Let me know if you have any more.
ASHLEY EVERETT
Philanthropy Coordinator